4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034665-25-000004
President and COO sold 50,500 shares at an average $18.06 ($911,842)
- President and COO acquired 32,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2025-10-06 | Option exercise 10b5-1 | +24,000 | $3.79 | $90,955 | 245,141 | D |
| Cohlhepp Ryan President and COO | 2025-10-06 | Sale 10b5-1 | −24,000 | $18.06 | $433,332 | 221,141 | D |
| Cohlhepp Ryan President and COO | 2025-10-06 | Sale 10b5-1 | −15,600 | $18.06 | $281,666 | 205,541 | D |
| Cohlhepp Ryan President and COO | 2025-10-07 | Option exercise 10b5-1 | +8,000 | $3.79 | $30,318 | 213,541 | D |
| Cohlhepp Ryan President and COO | 2025-10-07 | Sale 10b5-1 | −8,000 | $18.06 | $144,473 | 205,541 | D |
| Cohlhepp Ryan President and COO | 2025-10-07 | Sale 10b5-1 | −2,900 | $18.06 | $52,371 | 202,641 | D |
| Derivatives | |||||||
| Cohlhepp Ryan President and COO | 2025-10-06 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,000 | 173,334 | D | ||
| Cohlhepp Ryan President and COO | 2025-10-07 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,000 | 165,334 | D | ||
| Open-market sales · 50,500 sh · avg $18.06 · $911,842 | |||||||
Loading xslF345X05/wk-form4_1759959205.xml…